Literature DB >> 21034626

Effect of antioxidants on amelioration of high-risk factors inducing hypertensive disorders in pregnancy.

Jian-hua Lin1, Yi-ke Yang, Hua Liu, Qi-de Lin, Wei-yuan Zhang.   

Abstract

BACKGROUND: This is a prospective clinical study based on a large sample gathered from multiple centers in China, subordinating to 10th Five-Year Plan of National Science & Technology Progression. We analyzed the high-risk factors inducing hypertensive disorders in pregnancy (HDP) and estimated the potential effect of anti-oxidants administration, including vitamin C (VC), vitamin E (VE) and Salvia Miltiorrhiza L (SML), a Chinese herb medicine, in amelioration of the high-risk factors in pregnancy.
METHODS: From April 2005 to July 2006, 4814 pregnant women from 24 national wide cooperative hospitals were involved in this prospective research. The participants were randomly divided into two groups: 1607 cases were in anti-oxidants group with administration of vitamins and SML; 3207 cases were in control group without any medicine given. Every participant was under monitoring for the morbidity of HDP and the high-risk factors were investigated in HDP cases in each group.
RESULTS: (1) The morbidity of HDP was 3.55% in anti-oxidants group vs. 4.18% in control group. No statistical difference existed between the two groups (P > 0.05). (2) In anti-oxidants group, the HDP morbidities among three subgroups: VC + VE + SML, VC + VE and SML only, were 5.51%, 3.05% and 5% respectively. It showed no statistical difference among three remedies (P > 0.05). (3) The related index of factors affecting HDP showed in intensity sequence as follows: family HDP history > profession > education level > age > body weight. The incidence of HDP in normal population was 3.51%, and the incidence of HDP in high-risk pregnant women (family HDP history, heavy physical labor, low education level (middle school and below), age ≥ 40, body mass index ≥ 24) was 5.84%, which was obviously higher than that in normal population (P < 0.01). In anti-oxidants group, the probability of HDP in women with high-risk factors was 3.81%, which was obviously lower than that in control group with high-risk factors at 7.14% (P < 0.01). (4) In control group, the morbidity of HDP in women with family HDP history (especially with sisters'), heavy physical labor, middle school and below, age ≥ 35 was: 50.00%, 15.22%, 6.33%, 26.28% and 5.75%, respectively, and that in anti-oxidants group was 0, 7.69%, 3.74%, 9.27% and 2.67%, respectively, which was obviously lower than that in control group.
CONCLUSIONS: The high-risk factors prone to induce HDP included: family history of HDP, heavy physical labor, low education level, aging and obesity. No impressive effect of anti-oxidants application was found in preventing HDP in general population but the remedy demonstrated positive effect on preventing HDP in pregnant women with high-risk factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034626

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

Review 1.  Vitamin supplementation for preventing miscarriage.

Authors:  Olukunmi O Balogun; Katharina da Silva Lopes; Erika Ota; Yo Takemoto; Alice Rumbold; Mizuki Takegata; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

2.  Reactive Oxygen Species are Essential for Placental Angiogenesis During Early Gestation.

Authors:  Yike Yang; Huili Jin; Yuhan Qiu; Yamin Liu; Li Wen; Yong Fu; Hongbo Qi; Philip N Baker; Chao Tong
Journal:  Oxid Med Cell Longev       Date:  2022-06-01       Impact factor: 7.310

3.  The vascular effects of sodium tanshinone IIA sulphonate in rodent and human pregnancy.

Authors:  Jude S Morton; Irene J Andersson; Po-Yin Cheung; Philip Baker; Sandra T Davidge
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

4.  Morbidity and maternal and infant outcomes of hypertensive disorder in pregnancy in China in 2018.

Authors:  Xin Lyu; Weiyuan Zhang; Jingxiao Zhang; Yuqian Wei; Xiaoli Guo; Shihong Cui; Jianying Yan; Xiaoyan Zhang; Chong Qiao; Rong Zhou; Weirong Gu; Xianxia Chen; Yang Zi; Xiaotian Li; Yanyan Song; Jianhua Lin
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-03-31       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.